Market Closed -
Nyse
04:00:02 2024-05-01 pm EDT
|
5-day change
|
1st Jan Change
|
72.22
USD
|
-1.15%
|
|
-5.21%
|
-2.68%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
26,015
|
34,805
|
48,081
|
46,439
|
39,643
|
38,557
|
-
|
-
|
Enterprise Value (EV)
1 |
27,618
|
40,784
|
53,801
|
52,385
|
40,279
|
41,051
|
37,640
|
33,567
|
P/E ratio
|
20
x
|
19.2
x
|
36.1
x
|
39.6
x
|
15
x
|
12.2
x
|
11
x
|
9.51
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
2.31%
|
-
|
Capitalization / Revenue
|
0.35
x
|
0.31
x
|
0.38
x
|
0.32
x
|
0.26
x
|
0.26
x
|
0.26
x
|
0.24
x
|
EV / Revenue
|
0.37
x
|
0.37
x
|
0.43
x
|
0.36
x
|
0.26
x
|
0.28
x
|
0.26
x
|
0.21
x
|
EV / EBITDA
|
9.87
x
|
8.2
x
|
9.8
x
|
11.3
x
|
7.36
x
|
8.65
x
|
7.44
x
|
6.23
x
|
EV / FCF
|
36.7
x
|
8.8
x
|
16.3
x
|
9.96
x
|
5.55
x
|
20.5
x
|
8.68
x
|
7.78
x
|
FCF Yield
|
2.73%
|
11.4%
|
6.12%
|
10%
|
18%
|
4.87%
|
11.5%
|
12.8%
|
Price to Book
|
2.08
x
|
1.35
x
|
1.79
x
|
1.88
x
|
1.53
x
|
1.41
x
|
1.26
x
|
1.17
x
|
Nbr of stocks (in thousands)
|
413,796
|
579,798
|
583,503
|
566,260
|
534,201
|
533,656
|
-
|
-
|
Reference price
2 |
62.87
|
60.03
|
82.40
|
82.01
|
74.21
|
72.25
|
72.25
|
72.25
|
Announcement Date
|
2/4/20
|
2/9/21
|
2/8/22
|
2/7/23
|
2/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
74,639
|
111,115
|
125,982
|
144,547
|
153,999
|
149,260
|
145,818
|
161,231
|
EBITDA
1 |
2,799
|
4,972
|
5,490
|
4,624
|
5,475
|
4,746
|
5,062
|
5,391
|
EBIT
1 |
2,414
|
4,432
|
4,014
|
3,888
|
4,182
|
3,909
|
4,277
|
4,904
|
Operating Margin
|
3.23%
|
3.99%
|
3.19%
|
2.69%
|
2.72%
|
2.62%
|
2.93%
|
3.04%
|
Earnings before Tax (EBT)
1 |
1,782
|
2,773
|
1,813
|
1,962
|
3,598
|
4,192
|
4,510
|
4,830
|
Net income
1 |
1,321
|
1,808
|
1,347
|
1,202
|
2,702
|
3,099
|
3,251
|
3,689
|
Net margin
|
1.77%
|
1.63%
|
1.07%
|
0.83%
|
1.75%
|
2.08%
|
2.23%
|
2.29%
|
EPS
2 |
3.140
|
3.120
|
2.280
|
2.070
|
4.950
|
5.945
|
6.544
|
7.594
|
Free Cash Flow
1 |
753
|
4,634
|
3,295
|
5,257
|
7,254
|
1,999
|
4,336
|
4,312
|
FCF margin
|
1.01%
|
4.17%
|
2.62%
|
3.64%
|
4.71%
|
1.34%
|
2.97%
|
2.67%
|
FCF Conversion (EBITDA)
|
26.9%
|
93.2%
|
60.02%
|
113.69%
|
132.49%
|
42.12%
|
85.66%
|
79.98%
|
FCF Conversion (Net income)
|
57%
|
256.31%
|
244.62%
|
437.35%
|
268.47%
|
64.5%
|
133.38%
|
116.9%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
1.667
|
-
|
Announcement Date
|
2/4/20
|
2/9/21
|
2/8/22
|
2/7/23
|
2/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
32,568
|
37,185
|
35,936
|
35,865
|
35,561
|
38,889
|
37,608
|
38,042
|
39,460
|
40,407
|
35,948
|
36,245
|
36,795
|
40,412
|
37,736
|
EBITDA
1 |
1,062
|
1,742
|
1,735
|
1,156
|
472
|
1,534
|
1,528
|
1,541
|
434
|
1,376
|
1,424
|
1,258
|
530.5
|
1,574
|
1,520
|
EBIT
1 |
684
|
1,551
|
1,537
|
976
|
305
|
1,371
|
1,382
|
1,393
|
119
|
1,241
|
1,155
|
1,026
|
402.1
|
1,484
|
1,285
|
Operating Margin
|
2.1%
|
4.17%
|
4.28%
|
2.72%
|
0.86%
|
3.53%
|
3.67%
|
3.66%
|
0.3%
|
3.07%
|
3.21%
|
2.83%
|
1.09%
|
3.67%
|
3.4%
|
Earnings before Tax (EBT)
1 |
694
|
1,148
|
-236
|
1,009
|
41
|
1,391
|
1,415
|
768
|
24
|
1,473
|
1,301
|
1,164
|
278
|
1,561
|
1,367
|
Net income
1 |
599
|
849
|
-172
|
738
|
-213
|
1,130
|
1,058
|
469
|
45
|
1,163
|
913.8
|
823.9
|
223.7
|
1,121
|
966.6
|
Net margin
|
1.84%
|
2.28%
|
-0.48%
|
2.06%
|
-0.6%
|
2.91%
|
2.81%
|
1.23%
|
0.11%
|
2.88%
|
2.54%
|
2.27%
|
0.61%
|
2.77%
|
2.56%
|
EPS
2 |
1.010
|
1.440
|
-0.2900
|
1.270
|
-0.3800
|
2.040
|
1.920
|
0.8700
|
0.0800
|
2.160
|
1.742
|
1.604
|
0.4680
|
2.194
|
1.942
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/8/22
|
4/26/22
|
7/26/22
|
10/25/22
|
2/7/23
|
4/25/23
|
7/28/23
|
10/24/23
|
2/6/24
|
4/26/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,603
|
5,979
|
5,720
|
5,946
|
636
|
2,494
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
916
|
4,990
|
Leverage (Debt/EBITDA)
|
0.5727
x
|
1.203
x
|
1.042
x
|
1.286
x
|
0.1162
x
|
0.5255
x
|
-
|
-
|
Free Cash Flow
1 |
753
|
4,634
|
3,295
|
5,257
|
7,254
|
1,999
|
4,336
|
4,312
|
ROE (net income / shareholders' equity)
|
15.8%
|
15.1%
|
5.12%
|
13.2%
|
14.6%
|
13.5%
|
13.4%
|
13.4%
|
ROA (Net income/ Total Assets)
|
5.17%
|
3.3%
|
1.83%
|
4.33%
|
4.51%
|
4.14%
|
4.26%
|
4.27%
|
Assets
1 |
25,572
|
54,857
|
73,547
|
27,752
|
59,846
|
74,881
|
76,241
|
86,342
|
Book Value Per Share
2 |
30.20
|
44.30
|
46.00
|
43.70
|
48.30
|
51.10
|
57.20
|
62.00
|
Cash Flow per Share
2 |
3.530
|
9.500
|
7.120
|
10.80
|
14.80
|
4.450
|
11.20
|
-
|
Capex
1 |
730
|
869
|
910
|
1,004
|
799
|
655
|
832
|
857
|
Capex / Sales
|
0.98%
|
0.78%
|
0.72%
|
0.69%
|
0.52%
|
0.44%
|
0.54%
|
0.53%
|
Announcement Date
|
2/4/20
|
2/9/21
|
2/8/22
|
2/7/23
|
2/6/24
|
-
|
-
|
-
|
Last Close Price
72.25
USD Average target price
88.02
USD Spread / Average Target +21.82% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.68% | 38.99B | | +11.30% | 123B | | +19.28% | 101B | | -31.37% | 36.4B | | -6.21% | 20.05B | | -13.15% | 3.08B | | -39.37% | 982M | | -32.49% | 312M |
Other Managed Healthcare
|